#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies
Falha ao colocar no Carrinho.
Falha ao adicionar à Lista de Desejos.
Falha ao remover da Lista de Desejos
Falha ao adicionar à Biblioteca
Falha ao seguir podcast
Falha ao parar de seguir podcast
#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies
-
Narrado por:
-
De:
Sobre este áudio
Karl Herrup, Michelle Jin, and James Noble share their perspectives on evaluating the clinical impacts of emerging treatments for Alzheimer’s Disease with eNeuro Editor-in-Chief Christophe Bernard. Find our upcoming webinar schedule here.
With special guests:
Karl Herrup, Michelle Jin, and James Noble
Hosted by:
Christophe Bernard
On Neuro Current, we delve into the stories and conversations surrounding research published in the journals of the Society for Neuroscience. Through its publications, JNeurosci, eNeuro, and the History of Neuroscience in Autobiography, SfN promotes discussion, debate, and reflection on the nature of scientific discovery, to advance the understanding of the brain and the nervous system.
Find out more about SfN and connect with us on X, Instagram, and LinkedIn.